Immune response to mycobacteria

Current Immunology Reviews

Volumn 7, Issue 1, 2011, Pages 13-18

  Del Mar Casal, María ^a   Casal, Manuel ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Atypical mycobacteria; Immune response; Mycobacterium bovis; Mycobacterium leprae; Mycobacterium tuberculosis

Indexed keywords

BACTERIAL ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; RANTES; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; GRANULOMA; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INTERFERON PRODUCTION; LEPROMATOUS LEPROSY; MACROPHAGE; MEDIATOR RELEASE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TH3 CELL; TUBERCULOID LEPROSY;

EID: 79551662644     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339511794474280     Document Type: Article

References (38)

1. Flynn JL. Immunology of tuberculosis and implications in vaccinedevelopment. Tuberculosis (Edinb) 2004; 84: 93-101.
2. Flynn JL, Ernst JD. Immune responses in tuberculosis. Curr Opin Immunol 2000; 12: 432-6.
3. Flynn JA, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19: 93-129.
4. North RJ, Yung YJ. Immunity to tuberculosis. Annu Rev Immunol 2004; 22: 599-623.
5. Raja A. Immunology of tuberculosis. Indian J Med Res 2004; 120: 213-32.
6. Van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002; 15: 294-309.
7. Berrington WR, Hawn TR. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variationmatter? Immunol Rev 2007; 219: 167-86.
8. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009; 27: 393-422.
9. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163: 3920-7.
10. Underhííl DM, Ozinsky A, Smith KD, Aderem A. Toll-likereceptor-2 mediates mycobacteria-induced proinflammatory signallingin macrophages. Proc Natl Acad Sci USA 1999; 96: 14459-63.
11. Cooper AM, Adams LB, Dalton DK, Appelberg R, Ehlers S. IFNgammaand NO in mycobacterial disease: new jobs for old hands. Trends Microbiol 2002; 10: 221-6.
12. Teitelbaum R, Cammer M, Maitland ML, Freitag NE, Condeelis J, Bloom BR. Mycobacterial infection of macrophages results inmembrane-permeable phagosomes. Proc Natl Acad Sci USA 1999; 96: 15190-5.
13. Noss EH, Pai RK, Sellati TJ, et al. Toll-like receptor 2-dependentinhibition of macrophage class II MHC expression and antigenprocessing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 2001; 167: 910-8.
14. Song CH, Kim HJ, Park JK, et al. Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32- kilodaltonmycobacterial antigen in patients with active pulmonarytuberculosis. Infect Immun 2000; 68: 4477-84.
15. Algood HM, Chan J, Flynn JL. Chemokines and tuberculosis. Cytokine Growth Factor Rev 2003; 14: 467-77.
16. Fenhalls G, Wong A, Bezuidenhout J, van Helden P, Bardin P, Lukey PT. In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculousgranulomas. Infect Immun 2000; 68: 2827-36.
17. Munk ME, Mayer P, Anding P, Feldmann K, Kaufmann SH. Increased numbers of interleukin-12-producing cells in humantuberculosis. Infect Immun 1996; 64: 1078-80.
18. Cooper AM, Khader SA. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 2008; 226: 191-204.
19. Quiroga MF, Pasquinelli V, Martinez GJ, et al. Induciblecostimulator: a modulator of IFN-gamma production in humantuberculosis. J Immunol 2006; 176: 5965-74.
20. Havlir DV, Wallis RS, Boom WH, Daniel TM, Chervenak K, Ellner JJ. Human immune response to Mycobacerium tuberculosisantigens. Infect Immun 1991; 59: 665-70.
21. Chang Z, Choudhary A, Lathigra R, Quiocho FA. Theimmunodominant 38-kDa lipoprotein antigen of Mycobacteriumtuberculosis is a phosphate-binding protein. J Biol Chem 1994; 269: 1956-8.
22. Rees AD, Faith A, Roman E, Ivanyi J, Wiesmuller KH, Moreno C. The effect of lipoylation on CD4 T-cell recognition of the 19, 000MW Mycobacterium tuberculosis antigen. Immunology 1993; 80: 407-14.
23. Pai RK, Pennini ME, Tobian AA, Canaday DH, Boon WH, Harding CV. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoproteininhibits interferon-induced regulation of selected genes inmacrophages. Infect Immun 2004; 72: 6603-14.
24. Wang X, Barnes PF, Dobos-Elder KM, et al. ESAT-6 inhibitsproduction of IFN-gamma by Mycobacterium tuberculosisresponsivehuman T cells. J Immunol 2009; 182: 3668-77.
25. Wiker HG, Harboe M. The antigen 85 complex: a major secretionproduct of Mycobacterium tuberculosis. Microbiol Rev 1992; 56: 648-61.
26. Hovav AH, Mullerad J, Davidovitch L, et al. The Mycobacteriumtuberculosis recombinant 27-kilodalton lipoprotein induces a strongTh1-type immune response deleterious to protection. Infect Immun 2003; 71: 3146-54.
27. Britton WJ. Immunology of leprosy. Trans R Soc Trop Med Hyg 1993; 87: 508-14.
28. Han XY, Seo YH, Sizer KC, et al. A new Mycobacterium speciescausing diffuse lepromatous leprosy. Am J Clin Pathol 2008; 130: 856-64.
29. Doffinger R, Altare F, Casanova JL. Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection. Microbes Infect 2000; 2: 1553-7.
30. Moraes-Vasconcelos D, Beaucoudrey L, Grumach A, et al. Investigation of the IL-12-IFN-gamma axis in two patients withdisseminated mycobacteriosis. Clin Immunol 2006; 119: 145-6.
31. Altare FA, Durandy A, Lammas D, et al. Impairment ofmycobacterial immunity in human interleukin-12 receptordeficiency. Science 1998; 280: 1432-5.
32. Newport MJ, Huxley CM, Huston S, et al. A mutation in theinterferon-gamma-receptor gene and susceptibility to mycobacterialinfection. N Engl J Med 1996; 335: 1941-9.
33. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, et al. A humanIFNGR1 small deletion hotspot associated with dominantsusceptibility to mycobacterial infection. Nat Genet 1999; 21: 370-8.
34. Remiszewski P, Roszkowska-Sliz B, Winek J, et al. Disseminated Mycobacterium avium infection in a 20-year-old female withpartial recessive IFNgamma R1 deficiency. Respiration 2006; 73: 375-8.
35. Chapgier A, Boisson-Dupuis S, Jouanguy E, et al. Novel STAT1alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet 2006; 2: 131.
36. Filipe-Santos O, Bustamante J, Haverkamp MH, et al. X-linkedsusceptibility to mycobacteria is caused by mutations in NEMOimpairing CD40-dependent IL-12 production. J Exp Med 2006; 203: 1745-59.
37. Bustamante J, Picard C, Fieschi C, et al. A novel X-linkedrecessive form of Mendelian susceptibility to mycobaterial disease. J Med Genet 2007; 44: e65.
38. Filipe-Santos O, Bustamante J, Chapgier A, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006; 18: 347-61.